Skip to content
TrialScanner

NCT04843319

To Determine an Effective Dose of VERU-100 for the Treatment of Advanced Prostate Cancer

Phase 1/Phase 2TerminatedVERULead

Registry record

Lead sponsor
Veru Inc.
Conditions
Advanced Prostate Adenocarcinoma
Primary completion
Jan 19, 2023Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT04843319 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT04843319: To Determine an Effective... | TrialScanner